Science News
Gene fusion shifts cell activity into high gear, causing some cancer
Credit: Iavarone Lab, Columbia University Medical Center New York, NY (January 3, 2017)--The fusion of two adjacent genes can cause...
Scientists design bacteria to reflect ‘sonar’ signals for ultrasound imaging
Credit: Anupama Lakshmanan/Caltech In the 1966 science fiction film Fantastic Voyage, a submarine is shrunken down and injected into a...
Virus could treat brain tumours by boosting immune system
A virus injected directly into the bloodstream could be used to treat people with aggressive brain tumours, a major new...
New research shows how alcohol damages DNA and increases cancer risk
Scientists have shown how alcohol damages DNA in stem cells, helping to explain why drinking increases your risk of cancer,...
Could viruses take cancer immunotherapy to the next level?
Credit: The Ottawa Hospital The Alliance for Cancer Gene Therapy (ACGT), a non-profit based in Stamford, Connecticut, dedicated to funding...
In clinical trial, cream reduces squamous cell carcinoma risk
PROVIDENCE, R.I. -- New results from a clinical trial involving more than 900 military veterans at high risk for keratinocyte...
Tailoring cancer treatments to individual patients
Credit: Lima et. al. 2017, Hormuth et. al. 2015 Attempts to eradicate cancer are often compared to a "moonshot" --...
Trastuzumab: No negative impact on cardiac function
PITTSBURGH, PA -- Long-term follow-up results of the NRG Oncology trial NSABP B-31 have shown that the addition of trastuzumab...
Total-body PET: Maximizing sensitivity for clinical research and patient care
Credit: University of California, Davis RESTON, Va. - The new total-body PET/CT scanner could revolutionize our understanding and treatment of...
PharmaMar has requested the process of re-examination for Aplidin® from the EMA
(Pharmamar) PharmaMar (MSE:PHM) has announced the initiation of the re-examination process by the European Medicines Agency (EMA) for Aplidin® (plitidepsin)...
State-of-the-art MRI technology bypasses need for biopsy
Credit: UT Southwestern DALLAS - Jan. 02, 2018 - The most common type of tumor found in the kidney is...
Americans’ attitudes about science in 2017: High confidence, low visibility
ARLINGTON, Va. - Jan. 2, 2018 - Scientists and the nation's scientific enterprise remain largely invisible to the public, according...
Novel nanomedicine inhibits progression of pancreatic cancer in mice
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene -- a gene that promotes the...
Randomness a key in spread of disease, other ‘evil’
ITHACA, N.Y. - An unfortunate church dinner more than 100 years ago did more than just spread typhoid fever to...
Novel diabetes drugs sensitize cancer cells to chemotherapy agents
Scientists at Dana-Farber Cancer Institute have shown that experimental diabetes drugs can make cancer cells more vulnerable to traditional chemotherapy...
PharmaMar signs a license agreement for Aplidin® with Megapharm in Israel
PharmaMar (MSE:PHM) has announced today a commercialization and distribution license agreement with Megapharm Ltd. for the marine-derived anticancer drug Aplidin®...
Immune cells play key role in early breast cancer metastasis even before a tumor develops
(New York, NY - January 2, 2018) --Mount Sinai researchers have discovered that normal immune cells called macrophages, which reside...
Risk-based lung cancer screening may save more lives than current USPSTF guidelines
1. Risk-based lung cancer screening may save more lives than current USPSTF guidelines Abstract: http://annals.org/aim/article/doi/10.7326/M17-2067 URLs go live when the...
New guidelines on clinical trial design for patients with brain metastases
Credit: University of Colorado Cancer Center Clinical trials of new anti-cancer therapies have often excluded patients whose disease has spread...
Berry gives boost to cervical cancer therapy
Credit: University of Missouri School of Medicine According to the Centers for Disease Control and Prevention, approximately 12,000 women in...
